Point Defiance Aids Project is categorized under Clinics in Tacoma, WA and active since 1988.
Point Defiance Aids Project was established in 1988, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6219990 by the NAICS.
If you are seeking more information, feel free to contact David Purchase, Executive Director at the company’s single location by writing to 535 Dock St # 112, Tacoma, Washington WA 98402 or by phoning (253) 272-4857. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Point Defiance Aids Project |
| Contact Person: | David Purchase, Executive Director |
| Address: | 535 Dock St # 112, Tacoma, Washington 98402 |
| Phone Number: | (253) 272-4857 |
| Website Address: | nasen.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1988 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Clinics |
| SIC Code: | 8011 |
| NAICS Code: | 6219990 |
| Share This Business: |
Point Defiance Aids Project was started in 1988 to provide professional Clinics under the SIC code 8011 and NAICS code 6219990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact David Purchase, Executive Director for inquiries that concern Point Defiance Aids Project by calling the company number (253) 272-4857, as your correspondence is most welcome. Additionally, the physical location of the single location of Point Defiance Aids Project can be found at the coordinates 47.259581,-122.43861 as well as the street address 535 Dock St # 112 in Tacoma, Washington 98402.
For its online presence, you may visit Point Defiance Aids Project’s website at nasen.org and engage with its social media outlets through on Twitter and on Facebook.